JAMES ADAMS
NATIONAL ARTS CORRESPONDENT
Supporters of socialized health care in Canada and the United States have a seemingly unlikely friend in Rex Morgan M.D., the handsome,
Dividing up health care by income class
By Uwe E. Reinhardt
FEDERAL BUDGETS can be viewed as memorand ums in which the president and the majority of the Congress tell God about the
Spring Meeting Agenda
In MS Word format.
The Rise of For Profit Medicine
By Uwe E. Reinhardt
FROM THE perspective of someone whose social ethic was forged first in Europe and then in Canada, the current brouhaha over ''boutique
Health Care for All – Oregon
Folk,Ê
A conservative call for universal access to health care
By Donald W. Light, Ph.D.Commonweal, February 22, 2002By Donald W. Light, Ph.D. | Commonweal
The United States remains the only industrialized or second-tier country in the
For-Profit Health Care: Expensive, Inefficient and Inequitable
Dr. Arnold S. Relman, Professor Emeritus of Medicine and Social Medicine at Harvard Medical School and Emeritus Editor-in-Chief of the New England Journal of Medicine,
Glaxo Attempts to Block Access To Generic AIDS Drugs in Ghana
Mark Schoofs
Staff Reporter, The Wall Street Journal
In the midst of the wrenching international debate over how to get expensive HIV drugs into Africa, pharmaceutical giant
Universal health insurance makes business sense
November 2, 2001
By ROBERT F. SMITH
Herald Correspondent
The argument for a health care system in Vermont
Whenever Vermont health care is mentioned, what is really referred to is an arrangement that does not rise to the level of a system. This
The Double-Edged Helix
By Kathleen Kennedy Townsend
Lieutenant Governor of Maryland
Originally published in the Washington Monthly, November 1997
Advances in genetic testing reveal yet another reason we need national health
New Report Debunks Drug Industry Claims About the Cost of New Drug Research and Development
Second Report Documents Industry's Intense Lobby and Political Contribution Campaign to Keep Prices and Profits High
WASHINGTON, D.C. - The pharmaceutical industry spends about one-fifth of